AstraZeneca’s COVID-19 antibody jab approved for adults medically unsuitable for vaccination: HSA

SINGAPORE: The Health Sciences Authority (HSA) on Monday (Aug 1) granted temporary authorisation for AstraZeneca’s COVID-19 antibody medication for adults who are medically unsuitable for vaccination against the coronavirus. The Evusheld treatment comprises  2 monoclonal antibodies and it is administered via intramuscular injection.   HSA said the treatment is approvedContinue Reading